Biotech pharma

Quinn

Website
Founded 2022Origin source ↗Checked 2026-09-15

Overview

Quinn is your biopharma team. From molecule design to portfolio strategy, Quinn delivers comprehensive reports and supporting analyses, models and designs in 3–5 days instead of months.

Company description As recorded 2026-11-08

Founders & team

Previously iollo

Company history As recorded 2026-11-08

Daniel Gomari

Founder/CEO

Daniel Gomari is the founder and CEO of Quinn. A Stanford postdoc and PhD in Computational Biology, his work spanned ML for drug repurposing across cancer and metabolic disease, and multi-omics studies on aging and lifespan extension. He built Quinn after watching the pharma industry make billion-dollar R&D decisions on intuition and slide decks instead of computational evidence.

Founder profile As recorded 2026-09-15
5team members reported
Source-reported As recorded 2026-09-15

Founded 2022 · Source

News & product activity

Sources & observations

Y Combinator

Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedSan Francisco, CA, USA
Pricing evidenceNo pricing page confirmed
Maturity: Operating · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The company website explicitly reports customer or user adoption. This is a source-based assessment of a company claim; scale and revenue are not independently verified.

Company website: home Checked 2026-09-16

Trusted by teams at

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding year